Neogen Corporation · NASDAQ:NEOG
Neogen — Wells Fargo Healthcare Conference 2024
13 slides from Neogen's conference presentation, Sep 5, 2024
Slide 1: Wells Fargo Healthcare Conference
Wells Fargo Healthcare Conference September 5, 2024
Slide 2: Disclaimer: Forward Looking Statements
Disclaimer Forward Looking Statements This presentation includes “forward-looking statements” as that term is defined in Section 21E of the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are generally identified b
Slide 3: Our Purpose and Our Vision
Global food security is a lofty goal. Our Purpose But it’s one we’re uniquely positioned to We’re fueling a brighter future for global achieve. For over 40 years we’ve made it our food security. mission to keep our food supply safe. To further human and animal well-being. Our Vision To champion sust
Slide 4: Neogen at a glance: founded 1982, nearly 40 countries
1982 Founded in with a $50,000 grant from Michigan State University Headquarters Lansing, MI USA ~3,000 Employees Worldwide 300+ Scientists and Engineers Sales and support presence in nearly 40 countries © 2024 Neogen Corporation. All rights reserved. | 4
Slide 5: Global Leader in Food Security
Global Leader in Food Security Food Safety Animal Safety Protecting the Food Supply Ensuring Wellbeing • Food safety products that reach all segments of the • Develop solutions for animal protein, animal food, beverage and feed industries performance and companion animal segments • Solutions include
Slide 6: A Global Presence
A Global Presence North America Europe Lansing, MI • Canada • Denmark Headquarters • United States • Estonia New Production Facility • France Latin America • Germany • Argentina • Greece • Brazil • Hungary • Central America • Ireland • Chile • Italy • Colombia • Netherlands • Guatemala • Norway • Me
Slide 7: Leading Portfolio of Consumables
Leading Portfolio of Consumables Indicator Testing and Bacterial and Allergens Culture Media General Sanitation and Natural Toxins Animal Safety Products Genomics Petrifilm Pathogen Detection Allergen Testing Veterinary Instruments, Production Animal Animal Care Culture Media Hygiene Monitoring Natu
Slide 8: Well-Positioned to Address Global Food Security Challenges
Well-Positioned to Address Global Food Security Challenges …with Attractive Long-Term …Addressed by a Comprehensive Serving Large and Growing Markets… Fundamentals… Offering of Global Solutions Est. Market Size Est. LT Growth Rate Significant Tailwinds Product Categories • Increasing prevalence of f
Slide 9: Integrated Offering Enables Food Security for All
Integrated Offering Enables Food Security for All Animal Producers Food Processors Commodity Processors Food Retail Regulatory Crop Farmers Consumer Food Security Organism Testing, Allergen Testing, Hygiene Monitoring, Nutritional Analysis More, safer food, with Genomic Improvement reduced waste Pat
Slide 10: Driving Growth Across the Global Food Security Chain
Driving Growth Regulatory Focus Across the Global Food Genomic Security Chain Improvement Feed Production Leveraging Core Capabilities Agriculture & Farm Production • Foundational diagnostics capabilities and expertise ̶ Microbiology ̶ Immunoassays • Food safety end market, as well as attractive adj
Slide 11: Integration Fully Underway
Integration Fully Underway Manufacturing Transition Current Status Construction of facility complete, initial Post-Integration Indicator Testing equipment installation underway Expectations Relocation of equipment complete, Sample Handling production ramping up MSD-HSD annual core revenue growth (1)
Slide 12: Q1 FY25 Update
Q1 FY25 Update • Improvement in order fulfillment rates sustained • Preliminary view of revenue is in line with expectations communicated on Q4 earnings call • Encouraging response to initial demand recovery efforts © 2024 Neogen Corporation. All rights reserved. | 12
Slide 13: Investment Highlights
Investment Highlights • Clear leader in attractive Food Safety end market with long-term, secular tailwinds • Portfolio of over 95% consumable products, cost of which is insignificant relative to potential costs resulting from inadequate testing • Opportunity to leverage technological expertise, sca